Getting a BMS diagnosis can be difficult ... It may take time to find the treatment that works for you. Check in with your ...
With the failure of AbbVie’s emraclidine in two mid-stage trials, Bristol Myers Squibb’s Cobenfy is 'sole muscarinic winner.' ...
Bristol Myers Squibb has linked its CD19-directed CAR-T cell therapy to sustained clinical responses in people with systemic ...
Company officials are promoting the new UWB BMS solution as accelerating the adoption of electric vehicles (EVs).
The partnership will assist BMS with its work to discover new chemical reactions that will aid in the development of novel pharmaceutical manufacturing routes that are more efficient and better for ...